Access to medicines: are patents the real barrier?
- How can access to essential medicines be improved in developing countries?
- How can we find a balance between the protection of intellectual property rights, needed for the long term development of new medicines, and the need to make these accessible to a broad public?
- What role can and should have the relevant stakeholders (e.g. governments, civil society, pharmaceutical companies) in addressing these challenges?
A panel featuring representatives from the private and public sector will touch on these issues and take questions from the audience.
A buffet lunch will be served before the event.
Wednesday, 14 November, 2012 - 15:30
Brussels Press Club
Rue Froissart 95Brussels